Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Diagnosed with my second case of Covid-19. (Even after 4 shots of Modema); This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Diagnosed with my second case of Covid-19. (Even after 4 shots of Modema)) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Diagnosed with my second case of Covid-19. (Even after 4 shots of Modema)). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (Diagnosed with my second case of Covid-19. (Even after 4 shots of Modema)) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant product use was reported.  It was reported that the patient started Paxlovid 2 days after positive test result. The patient experienced very rapid recovery (as compared to the first time patient had Covid-19), but patient had continuous metallic taste in mouth.  Company comment.  This spontaneous case concerns a 66  year  old, female patient, with no medical history reported, who experienced the unexpected, non  serious AESI of COVID  19. The patient received 4 doses of mRNA  1273 vaccine on an unspecified schedule. Temporal association cannot be assessed due to lack of information on onset date of the event and vaccination dates. The report stated that the patient experienced her second episode of COVID  19 and received treatment with Paxlovid (Nirmatrelvir, Ritonavir), with rapid recovery. She mentioned having a continuous metallic taste in her mouth. No further details were provided for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a 66  year  old, female patient, with no medical history reported, who experienced the unexpected, non  serious AESI of COVID  19. The patient received 4 doses of mRNA  1273 vaccine on an unspecified schedule. Temporal association cannot be assessed due to lack of information on onset date of the event and vaccination dates. The report stated that the patient experienced her second episode of COVID  19 and received treatment with Paxlovid (Nirmatrelvir, Ritonavir), with rapid recovery. She mentioned having a continuous metallic taste in her mouth. No further details were provided for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.